PRINTER'S NO. 1399
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
232
Session of
2019
INTRODUCED BY BARRAR, BIZZARRO, BOBACK, BURNS, CALTAGIRONE,
DeLUCA, DiGIROLAMO, HEFFLEY, HILL-EVANS, KORTZ, LONGIETTI,
MEHAFFIE, MILLARD, MURT, NEILSON, RYAN AND SONNEY,
APRIL 15, 2019
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
APRIL 15, 2019
A RESOLUTION
Designating May 16, 2019, as "Congenital Disorders of
Glycosylation (CDG) Awareness Day" in Pennsylvania.
WHEREAS, Congenital disorders of glycosylation (CDG) is a
group of rare metabolic disorders that affect normal organ
development and the neurological system, leaving children,
adolescents and adults impaired with significant physical and
developmental disabilities; and
WHEREAS, CDG is severely underdiagnosed and misdiagnosed with
approximately 1,200 cases diagnosed with CDG globally and only
160 cases of CDG currently reported in the United States; and
WHEREAS, Lack of public awareness and visibility of CDG
contributes to underdiagnosis and difficulties in accessing
specialized services and proper rehabilitation and support; and
WHEREAS, Early diagnosis of CDG is important to ensure timely
management of clinical complications, genetic counseling and
when available, treatment and therapeutic remedies; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
WHEREAS, The goal is to raise awareness and increase the
accurate and timely diagnosis of this rare group of inherited
metabolic disorders known as CDG; therefore be it
RESOLVED, That the House of Representatives designate May 16,
2019, as "Congenital Disorders of Glycosylation (CDG) Awareness
Day" in Pennsylvania.
20190HR0232PN1399 - 2 -
1
2
3
4
5
6